Applicant, as named in the Orange Book

Handa Oncol

Next listed expiry: Omcazio on 30 Jan 2044. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Omcazio · 3 strengths cabozantinib laurylsulfate	cabozantinib laurylsulfate	220613	30 Jan 2044	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.